Montreal, Canada · Founded 2001 · Privately Held (backing)
Developer of medical therapeutics designed for the treatment of central nervous system (CNS) diseases and cancer. Kainova Therapeutics is based in Montreal, Canada and was founded in 2001. Its last reported valuation was $92 million in May 2022. It has raised $114 million.
Last reported valuation
$92.0M
Oct 2026
Priced at
—
Total raised
$113.9M
Last round
—
Cap table — not yet on record
Kainova Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kainova Therapeutics with a free account
·The complete investor list: 14 names
·Watch Kainova Therapeutics: the Monday email on marks, rounds and moves
